Latest

Latest clinical trial News | Page 10

  • Latest clinical trial news stories and updates. What is happening today? All recent clinical trial news and developments. Live coverage and timeline of clinical trial. All you need to know about clinical trial.
Actinogen Medical closes $10 million rights issue offer
FivepHusion says first patient treated in paediatric brain cancer trial
How ancient virus is implicated in MND
Exercise may help overcome erectile dysfunction
Kidney disease patients needed for national trial
Exercise could help one of prostate cancer treatment’s most-common side effects
Kidney enzyme as a new target for treatment of high blood pressure, study reveals
Adrenocortical carcinoma: No mitotane for low risk of recurrence
Vaxxas awarded Wellcome grant for needle-free typhoid vaccine patch study
Optimizing tissue oxygenation in breast reduction surgery
Pill could provide alternative to weight loss surgery
Forxiga approved in China to reduce the risk of cardiovascular death and hospitalisation in adult patients with symptomatic chronic heart failure
Moderna launches regional research centre and headquarters to advance mRNA research
Biotron completes clinical phase of BIT225 COVID-19 clinical trial
Imugene licenses allogeneic CAR-T with a potential registration study in 2024
From bed bound to marathon runner
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
Dimerix announces successful completion of second DSMB review of ACTION3 trial
$2.7 million in MRFF grants for MS research and maternity studies
NSW’s pharmacy trial expands statewide starting Monday
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
Daily aspirin doesn’t prevent strokes in older, healthy people after all
Study shows ultra-low-dose 4-in-1 blood pressure pill would be cost-effective in Australia
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
Dimerix updates on expected timing of DMX-200 Phase 3 kidney trial outcome
Monash expert: New Nature Medicine study into the use of psychedelic substance, psilocybin, for the treatment of anorexia nervosa
One pill doesn’t fit all: cholesterol study reveals effects on lung function and brain size
Ketamine effective for treatment-resistant depression: clinical trial
Researchers look to arrest the development of Type 1 diabetes in children More children are getting Type 1 diabetes and Mater Researcher…
$5.5 million for research to reduce impact of loneliness on chronic disease
Sleep for bushfire survivors. Cane waste to rebuild soil health. The real carbon cost of your travel. Creating tri-sector careers
First cohort dosed in RECCE 327 rapid infusion UTI clinical trial
Ludwig Cancer Research study shows tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer
Improving patient outcomes for kidney transplants
Major funding boost for phage therapy manufacturing in NSW
New data supports current management of CO2 levels in cardiac arrest patients
Update on MDMA and psilocybin access and safeguards from 1 July 2023
Trial finds vitamin D supplements could prevent heart attacks in over 60s
Neuren opens first site in US for Prader-Willi syndrome Phase 2 trial
New psychedelic-assisted therapy trial aims to help cancer patients
Putting research in frame
Award-winning therapy brings light into darkness
Major Boost Into Childhood Cancer Research
Emerging health and medical research leaders are solving health problems and improving health care
PreBabe trial examines benefits of losing weight preconception
Medicinal cannabis is a ‘life-changing treatment’ for people with Tourette syndrome
ARC Research Hub to transform biopharmaceutical manufacturing
Aravax launches new Phase 2 trial of peanut allergy candidate

© 2026 - The National Tribune Australia